Overweight and obesity in men with prostate cancer do not constitute risk factors for biochemical recurrence

References

• Encuesta Nacional de Salud y Nutrición (ENSANUT). México: Secretaría de Salud, Instituto Nacional De Salud Pública, Instituto Nacional de Estadística y Geografía, México 2018. https://ensanut.insp.mx/
   Google Scholar
• Golabek T, Bukowczan J, Chlosta P, et al. Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urol Int. 2014;92(1):7–14.
   PubMed Web of Science ®Google Scholar
• Cantarutti A, Bonn SE, Adami HO, et al. Body mass index and mortality in men with prostate cancer. Prostate. 2015;75(11):1129–1136.
   PubMed Web of Science ®Google Scholar
• Hu MB, Xu H, Zhu WH, et al. High-fat diet-induced adipokine and cytokine alterations promote the progression of prostate cancer in vivo and in vitro. Oncol Lett. 2017;15(2):1607–1615.
   PubMed Web of Science ®Google Scholar
• Dickerman BA, Torfadottir JE, Valdimarsdottir UA, et al. Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study. Cancer. 2019;125(16):2877–2885.
   PubMed Web of Science ®Google Scholar
• Hu MB, Xu H, Bai PD, et al. Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients. Med Oncol. 2014;31(2):829.
   PubMed Web of Science ®Google Scholar
• Vidal AC, Howard LE, Moreira DM, et al. Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2936–2942.
   PubMed Web of Science ®Google Scholar
• Yamoah K, Zeigler-Johnson CM, Jeffers A, et al. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. BMC Cancer. 2016;16(1):557.
   PubMed Web of Science ®Google Scholar
• Vidal AC, Howard LE, Sun SX, et al. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Prostate Cancer Prostatic Dis. 2017;20(1):72–78.
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Branche BL, Howard LE, et al. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. BJU Int. 2019;124(1):69–75.
   PubMed Web of Science ®Google Scholar
• Wissing M, Chevalier S, McKercher G, et al. The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer. World J Urol. 2019;37(5):789–798.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Helfand BT, Jang TL, et al. Nuclear factor-κB-mediated transforming growth factor-β-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res. 2009;15(10):3557–3567.
   PubMed Web of Science ®Google Scholar
• Torrealba N, Vera R, Fraile B, et al. TGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer. Aging Male. 2019;1–11. DOI:10.1080/13685528.2019.1597840
   PubMed Web of Science ®Google Scholar
• DiGiovanni J, Kiguchi K, Frijhoff A, et al. Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA. 2000;97(7):3455–3460.
   PubMed Web of Science ®Google Scholar
• Roddam AW, Allen NE, Appleby P, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med. 2008;149(7):461–471, w83–w88.
   PubMed Web of Science ®Google Scholar
• Rabin-Court A, Rodrigues MR, Zhang XM, et al. Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation. PLOS One. 2019;14(6):e0218126.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zheng J, Yao X, et al. Adiponectin inhibits VEGF-A in prostate cancer cells. Tumor Biol. 2015;36(6):4287–4292.
   PubMedGoogle Scholar
• Tan W, Wang L, Ma Q, et al. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation. Prostate. 2015;75(11):1197–1205.
   PubMed Web of Science ®Google Scholar
• World Health Organization 2018. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
   Google Scholar
• D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969–974.
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Hudson MA, Scardino PT, et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol. 1994;152(6 Part 1):2037–2042.
   PubMed Web of Science ®Google Scholar
• Schiffmann J, Salomon G, Tilki D, et al. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression. Urol Oncol. 2017;35(5):243–249.
   PubMed Web of Science ®Google Scholar
• Tomaszewski JJ, Chen YF, Bertolet M, et al. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy. Urology. 2013;81(5):992–996.
   PubMed Web of Science ®Google Scholar
• Schiffmann J, Karakiewicz PI, Rink M, et al. Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients. World J Urol. 2018;36(7):1067–1072.
   PubMed Web of Science ®Google Scholar
• Lennon H, Sperrin M, Badrick E, et al. The Obesity Paradox in cancer: a review. Curr Oncol Rep. 2016;18(9):56.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Sperrin M. The Obesity Paradox and mortality after colorectal cancer: a causal conundrum. JAMA Oncol. 2016;2(9):1127–1129.
   PubMed Web of Science ®Google Scholar
• Ujvari B, Jacqueline C, Misse D, et al. Obesity paradox in cancer: is bigger really better? Evol Appl. 2019;12(6):1092–1095.
   PubMed Web of Science ®Google Scholar
• Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364(8):719–729.
   PubMed Web of Science ®Google Scholar
• Lainscak M, von Haehling S, Doehner W, et al. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2012;3(1):1–4.
   PubMed Web of Science ®Google Scholar
• Doehner W, von Haehling S, Anker SD. Protective overweight in cardiovascular disease: moving from ‘paradox’ to ‘paradigm’. Eur Heart J. 2015;36(40):2729–2732.
   PubMed Web of Science ®Google Scholar
• Huang SP, Huang CY, Liu CC, et al. Clinical outcome of Taiwanese men with clinically localized prostate cancer post-radical prostatectomy: a comparison with other ethnic groups. Aging Male. 2010;13(1):10–17.
   PubMed Web of Science ®Google Scholar
• Brassell SA, Rice KR, Parker PM, et al. Prostate cancer in men 70 years old or older, indolent or aggressive: clinico pathological analysis and outcomes. J Urol. 2011;185(1):132–137.
   PubMed Web of Science ®Google Scholar
• Ko J, Falzarano SM, Walker E, et al. Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart. Prostate. 2013;73(8):897–903.
   PubMed Web of Science ®Google Scholar
• Vukovic M, Kavaric P, Magdelinic A, et al. Perineural invasion on biopsy specimen as predictor of tumor progression in aging male treated with radical prostatectomy. Could we use it for pre-surgical screening? Aging Male. 2019;1–6. DOI:10.1080/13685538.2019.1581758
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al., editors. SEER cancer statistics review, 1975–2016. Bethesda (MD): National Cancer Institute. Available from: https://seer.cancer.gov/csr/1975_2016/.
   Google Scholar
• Encuesta Nacional de Salud y Nutrición Cuernavaca (ENSANUT). 2012. México: Instituto Nacional de Salud Pública. https://ensanut.insp.mx/encuestas/ensanut2012/index.php.
   Google Scholar